431 related articles for article (PubMed ID: 31248683)
1. Maternally-derived neutralizing antibodies reduce vaccine efficacy against porcine reproductive and respiratory syndrome virus infection.
Renson P; Fablet C; Andraud M; Normand V; Lebret A; Paboeuf F; Rose N; Bourry O
Vaccine; 2019 Jul; 37(31):4318-4324. PubMed ID: 31248683
[TBL] [Abstract][Full Text] [Related]
2. Effect of vaccination route (intradermal vs. intramuscular) against porcine reproductive and respiratory syndrome using a modified live vaccine on systemic and mucosal immune response and virus transmission in pigs.
Renson P; Mahé S; Andraud M; Le Dimna M; Paboeuf F; Rose N; Bourry O
BMC Vet Res; 2024 Jan; 20(1):5. PubMed ID: 38172908
[TBL] [Abstract][Full Text] [Related]
3. Antibody response and maternal immunity upon boosting PRRSV-immune sows with experimental farm-specific and commercial PRRSV vaccines.
Geldhof MF; Van Breedam W; De Jong E; Lopez Rodriguez A; Karniychuk UU; Vanhee M; Van Doorsselaere J; Maes D; Nauwynck HJ
Vet Microbiol; 2013 Dec; 167(3-4):260-71. PubMed ID: 24041768
[TBL] [Abstract][Full Text] [Related]
4. Vaccination with a porcine reproductive and respiratory syndrome virus vaccine at 1-day-old improved growth performance of piglets under field conditions.
Jeong J; Kim S; Park KH; Kang I; Park SJ; Yang S; Oh T; Chae C
Vet Microbiol; 2018 Feb; 214():113-124. PubMed ID: 29408022
[TBL] [Abstract][Full Text] [Related]
5. Vaccination with a genotype 1 modified live vaccine against porcine reproductive and respiratory syndrome virus significantly reduces viremia, viral shedding and transmission of the virus in a quasi-natural experimental model.
Pileri E; Gibert E; Soldevila F; García-Saenz A; Pujols J; Diaz I; Darwich L; Casal J; Martín M; Mateu E
Vet Microbiol; 2015 Jan; 175(1):7-16. PubMed ID: 25439650
[TBL] [Abstract][Full Text] [Related]
6. Maternally-derived antibodies (MDAs) impair piglets' humoral and cellular immune responses to vaccination against porcine reproductive and respiratory syndrome (PRRS).
Fablet C; Renson P; Eono F; Mahé S; Eveno E; Le Dimna M; Normand V; Lebret A; Rose N; Bourry O
Vet Microbiol; 2016 Aug; 192():175-180. PubMed ID: 27527780
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of commercial genotype 1 porcine reproductive and respiratory syndrome virus (PRRSV) vaccine against field isolate of genotype 2 PRRSV.
Ko SS; Seo SW; Sunwoo SY; Yoo SJ; Kim MH; Lyoo YS
Vet Immunol Immunopathol; 2016 Apr; 172():43-9. PubMed ID: 27032502
[TBL] [Abstract][Full Text] [Related]
8. Cross-protection of a modified-live porcine reproductive and respiratory syndrome virus (PRRSV)-2 vaccine against a heterologous PRRSV-1 challenge in late-term pregnancy gilts.
Jeong J; Park C; Oh T; Park KH; Yang S; Kang I; Park SJ; Chae C
Vet Microbiol; 2018 Sep; 223():119-125. PubMed ID: 30173737
[TBL] [Abstract][Full Text] [Related]
9. Recombinant Porcine Reproductive and Respiratory Syndrome Virus Expressing Membrane-Bound Interleukin-15 as an Immunomodulatory Adjuvant Enhances NK and γδ T Cell Responses and Confers Heterologous Protection.
Cao QM; Ni YY; Cao D; Tian D; Yugo DM; Heffron CL; Overend C; Subramaniam S; Rogers AJ; Catanzaro N; LeRoith T; Roberts PC; Meng XJ
J Virol; 2018 Jul; 92(13):. PubMed ID: 29643245
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of a modified live porcine reproductive and respiratory syndrome virus (PRRSV) vaccine in pigs naturally exposed to a heterologous European (Italian cluster) field strain: Clinical protection and cell-mediated immunity.
Martelli P; Gozio S; Ferrari L; Rosina S; De Angelis E; Quintavalla C; Bottarelli E; Borghetti P
Vaccine; 2009 Jun; 27(28):3788-99. PubMed ID: 19442420
[TBL] [Abstract][Full Text] [Related]
11. Porcine reproductive and respiratory syndrome virus (PRRSv) modified-live vaccine reduces virus transmission in experimental conditions.
Rose N; Renson P; Andraud M; Paboeuf F; Le Potier MF; Bourry O
Vaccine; 2015 May; 33(21):2493-9. PubMed ID: 25820061
[TBL] [Abstract][Full Text] [Related]
12. A comparison of two commercially available porcine reproductive and respiratory syndrome virus (PRRSV) modified-live virus vaccines analyzing the growth performance in 1-day-old vaccinated swine located on endemic farms co-circulating PRRSV-1 and PRRSV-2.
Yang S; Kang I; Jeong J; Oh T; Park KH; Park SJ; Ham HJ; Jin GR; Lee BH; Chae C
J Vet Med Sci; 2020 Feb; 82(2):224-228. PubMed ID: 31866631
[TBL] [Abstract][Full Text] [Related]
13. Natural infection with torque teno sus virus 1 (TTSuV1) suppresses the immune response to porcine reproductive and respiratory syndrome virus (PRRSV) vaccination.
Zhang Z; Wang Y; Fan H; Lu C
Arch Virol; 2012 May; 157(5):927-33. PubMed ID: 22327391
[TBL] [Abstract][Full Text] [Related]
14. Immune response and protective efficacy of intramuscular and intradermal vaccination with porcine reproductive and respiratory syndrome virus 1 (PRRSV-1) modified live vaccine against highly pathogenic PRRSV-2 (HP-PRRSV-2) challenge, either alone or in combination with of PRRSV-1.
Madapong A; Saeng-Chuto K; Chaikhumwang P; Tantituvanont A; Saardrak K; Pedrazuela Sanz R; Miranda Alvarez J; Nilubol D
Vet Microbiol; 2020 May; 244():108655. PubMed ID: 32402335
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of Fostera® PRRS modified live virus (MLV) vaccination strategy against a Thai highly pathogenic porcine reproductive and respiratory syndrome virus (HP-PRRSV) infection.
Charoenchanikran P; Kedkovid R; Sirisereewan C; Woonwong Y; Arunorat J; Sitthichareonchai P; Sopipan N; Jittimanee S; Kesdangsakonwut S; Thanawongnuwech R
Trop Anim Health Prod; 2016 Oct; 48(7):1351-9. PubMed ID: 27315207
[TBL] [Abstract][Full Text] [Related]
16. Cross-protective immunity to porcine reproductive and respiratory syndrome virus by intranasal delivery of a live virus vaccine with a potent adjuvant.
Dwivedi V; Manickam C; Patterson R; Dodson K; Murtaugh M; Torrelles JB; Schlesinger LS; Renukaradhya GJ
Vaccine; 2011 May; 29(23):4058-66. PubMed ID: 21419162
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of simultaneous vaccination with two modified live virus vaccines against porcine reproductive and respiratory syndrome virus types 1 and 2 in pigs.
Kristensen CS; Kvisgaard LK; Pawlowski M; Holmgaard Carlsen S; Hjulsager CK; Heegaard PMH; Bøtner A; Stadejek T; Haugegaard S; Larsen LE
Vaccine; 2018 Jan; 36(2):227-236. PubMed ID: 29191738
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of immune efficacy of recombinant PRRSV vectored vaccine rPRRSV-E2 in piglets with maternal derived antibodies.
Gao F; Jiang Y; Li G; Li L; Zhang Y; Yu L; Zheng H; Tong W; Zhou Y; Liu C; Shan T; Yu H; Kong N; Chen P; Tong G
Vet Microbiol; 2020 Sep; 248():108833. PubMed ID: 32891948
[TBL] [Abstract][Full Text] [Related]
19. Pigs immunized with Chinese highly pathogenic PRRS virus modified live vaccine are protected from challenge with North American PRRSV strain NADC-20.
Galliher-Beckley A; Li X; Bates JT; Madera R; Waters A; Nietfeld J; Henningson J; He D; Feng W; Chen R; Shi J
Vaccine; 2015 Jul; 33(30):3518-25. PubMed ID: 26049004
[TBL] [Abstract][Full Text] [Related]
20. Transmission of Porcine reproductive and respiratory syndrome virus 1 to and from vaccinated pigs in a one-to-one model.
Pileri E; Gibert E; Martín-Valls GE; Nofrarias M; López-Soria S; Martín M; Díaz I; Darwich L; Mateu E
Vet Microbiol; 2017 Mar; 201():18-25. PubMed ID: 28284607
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
